From: Antiviral activity of animal venom peptides and related compounds
Source | Species | Peptide name | Virus | Action mechanism | Reference |
---|---|---|---|---|---|
Frog | Xenopus laevis | Magainin 1 and 2 | HSV-1 and HSV-2 | Cellular target | [115] |
Frog | Rana brevipodaporsa | Brevinin-1 | HSV | Viral inactivation | [116] |
Frog | Phyllomedusa | Dermaseptin S4 | HSV-2 | Viral envelope disruption | [69] |
Frog | Phyllomedusa | Dermaseptin DS4 | HIV-1 | Viral envelope disruption | [117] |
Frog | – | Dermaseptin S4 | HSV-1 | Viral membrane disruption | [118] |
Frog | Litoria caerulea | Caerin 1.1 | HIV | Viral envelope disruption | [70] |
Frog | Litoria chloris | Caerin 1.9 | HIV | Viral envelope disruption | [70] |
Frog | Litoria genimaculata | Maculatin 1.1 | HIV | Viral envelope disruption | [70] |
Insect | Vespula lewisii | MP7-NH2 | HSV | Viral envelope disruption | [74] |
Insect | Apis mellifera | Melittin | HIV | CXCR4 and CCR5 tropic inhibition HIV-1 infectivity | [79] |
Insect | Synthetic (from melittin) | Hecate | HSV | Cellular target | [83] |
Insect | Bee venom | bvPLA2 | HIV | Virion entry blocking into host cell | [65] |
Insect | Synthetic (from bvPLA2) | p3bv | HIV | HIV glycoprotein fusion inhibition to CXCR4 cell receptor | [76] |
Insect | Calliphora vicina | Alloferons 1 and 2 | IAV/HSV | Immunomodulatory activity | [88] |
Insect | Hyalophora cecropia | Cecropin A-magainin 2 | HIV | Virion entry blocking into host cell | [85] |
Ophidian | Trimeresurus stejnegeri | TSV-LAO | HIV-1 | Syncytium formation inhibition and HIV-1 p24 antigen reduction | [60] |
Ophidian | Bothrops jararaca | BjarLAAO-I | DENV-3 | Infected cells reduction | [61] |
Ophidian | Crotalus durissus terrificus | PLA2 -Cdt | DENV, YFV | Virus envelope cleavage and protein destabilization | |
 |  |  | HIV | Gag p24 processing inhibition | |
Ophidian | Bothrops leucurus | BlK-PLA2; BlD-PLA2 | DENV | Viral RNA levels reduction | [65] |
Ophidian | Naja kaouthia (Naja siamensis) | Immunokine | HIV | CCR5 and CXCR4 receptors interaction | |
Marine sponge | Sidonops microspinosa | Microspinosamide | HIV | Cytopathic effect inhibition | [111] |
Marine sponge | Siliquariaspongia mirabilis and Stelletta clavosa | Mirabamides A-H | HIV | Viral glycoprotein fusion neutralization to the cell receptors | |
Marine sponge | Homophymia sp. | Homophymine A | HIV | Virion entry inhibition | [96] |
Marine sponge | Theonella sp. | Papuamides A and B | HIV | Virion entry inhibition | [106] |
Marine sponge | Theonella swinhoe | Theopapuamide A | HIV | Virion entry inhibition | |
Marine sponge | T. swinhoe and T. cupola | Koshikamides F, H | HIV | Virion entry inhibition | [104] |
Marine sponge | Siliquariaspongia mirabilis | Theopapuamide B | HIV | Viral envelope disruption | [108] |
Marine sponge | Siliquariaspongia mirabilis | Celebesides A–C | HIV | Virion entry inhibition | [108] |
Marine sponge | Callipelta sp. | Callipeltin A | HIV | Virion entry inhibition | [109] |
Marine sponge | Neamphius huxleyi | Neamphamide A | HIV | Virion entry inhibition | [110] |
Horseshoe crab | Tachypleus tridentatus | Polyphemusin | HIV | Chemokine receptor, CXCR4/viral co-receptor attachment | [112] |
Fish | Pleuronectes americanus | Pa-MAP | HSV | Viral envelope interaction | |
Tunicate | Trididemnum solidum | Didemnins A, B and C | HSV-1 and 2; coxsackie virus A-21 and equine rhinovirus | Protein, DNA and RNA synthesis inhibition | [97] |